Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:10 AM
Ignite Modification Date:
2025-12-25 @ 1:10 AM
NCT ID:
NCT03248193
Eligibility Criteria:
The inclusion criterion for the healthy subjects:
* Age 21-80 years
* Signed informed consent from patient.
* No history of neuropathy
* ECOG 0
* No history of hospitalization in the past 6 months
The inclusion criteria for the cancer patients:
* Age 21- 80 years.
* Signed informed consent from patient
* Scheduled to receive weekly paclitaxel chemotherapy
For both healthy subjects and cancer patients:
* Open skin wound or ulcers of the limbs
* A score of more than 5 in the Total Neuropathy Score (TNS) at baseline (see outcome parameters) (Not applicable for healthy subjects)
* History of Raynaud's phenomenon, peripheral vascular disease, or poorly controlled diabetes
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
80 Years
Study:
NCT03248193
Study Brief:
Protocol Section:
NCT03248193